Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes

被引:9
作者
Turgut, M
Jellestad, FK
Mathisen, JR
Thorsen, T
Wester, K
Aakvag, A
机构
[1] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[2] Univ Bergen, Inst Physiol Psychol, N-5000 Bergen, Norway
[3] Univ Bergen, Inst Clin Biol, N-5021 Bergen, Norway
关键词
Parkinson's disease; substantia nigra; behaviour; sympathetic activity; 6-hydroxydopamine; rat;
D O I
10.1007/s004330050077
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the effects of experimental hemiparkinsonism upon sympathetic function in rat. The rats were divided into three groups: a group given intact control, one given lesioning with 6-hydroxydopamine (6-OHDA), and one given sham operation. One day after apomorphine testing following lesioning of the substantia nigra (SN) with 6-OHDA, heart rate (HR), mean arterial blood pressure (MAP), and electrocardiogram (EGG) were monitored. Plasma norepinephrine (NE), epinephrine (E), and dopamine (DA) levels were measured. Thereafter, immunohistochemical examination was performed to detect the extent of 6-OHDA lesions, using the avidinbiotinylated peroxidase complex (ABC) method. There was no difference in the total number of tyrosine hydroxylase (TH)-positive cells and rotation responses between the right- and left-sided 6-OHDA-treated groups. On the other hand, injury of rats with unilateral 6-OHDA resulted in haemodynamic, electrocardiographic, and biochemical changes. A significant difference was found between the right-sided 6-OHDA-treated rats and the left-sided treated ones. The MAP increased in the group given left 6-OHDA treatment and to lesser extent in the sham-operated group. In contrast, MAP did not increase in the group given right 6-OHDA treatment and was significantly lower than values in both the intact control rats and the sham-treated rats. Also, only the group given right 6-OHDA injury showed a fall in the value of HR. The plasma NE level was significantly decreased in the group given right 6-OHDA treatment compared with all other groups (P < 0.005). Our results indicate that right-sided lesioning of the nigrostriatal DA pathway in the central nervous system (CNS) has greater sympathetic consequences than left-sided ones. These results also suggest that there is a differential effect of right-sided SN lesions on sympathetic cardiac innervation. The mechanism behind the confronting impairment of autonomic nervous system (ANS) could in this experiment be attributable to an asymmetric representation of sympathetic function in the brain. However, further studies will be needed before final conclusions can be made.
引用
收藏
页码:281 / 292
页数:12
相关论文
共 50 条
  • [31] Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease
    Cui, Long-Biao
    Li, Bo-Wei
    Jin, Xiao-Hang
    Zhao, Lin
    Shi, Juan
    NEUROSCIENCE BULLETIN, 2010, 26 (05) : 381 - 387
  • [32] NEUROPROTECTIVE EFFECTS OF SWIMMING TRAINING IN A MOUSE MODEL OF PARKINSON'S DISEASE INDUCED BY 6-HYDROXYDOPAMINE
    Goes, A. T. R.
    Souza, L. C.
    Filho, C. B.
    Del Fabbro, L.
    De Gomes, M. G.
    Boeira, S. P.
    Jesse, C. R.
    NEUROSCIENCE, 2014, 256 : 61 - 71
  • [33] Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Ghalami, Jamileh
    Mojarad, Tourandokht Baluchnejad
    Mansouri, Monireh
    Khamse, Safoura
    Roghani, Mehrdad
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (01) : 43 - 55
  • [34] Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson's disease models
    Liu, Lan-Xiang
    Du, Dan
    Wang, Zhan-Qiu
    Fang, Yuan
    Zheng, Tao
    Dong, Yan-Chao
    Shi, Qing-Lei
    Zhao, Min
    Xiao, Fang
    Du, Juan
    NEURAL REGENERATION RESEARCH, 2018, 13 (07) : 1276 - 1280
  • [35] Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with μSPECT and quantitative MRI
    Van Camp, Nadja
    Vreys, Ruth
    Van Laere, Koen
    Lauwers, Erwin
    Beque, Dirk
    Verhoye, Marleen
    Casteels, Cindy
    Verbruggen, Alfons
    Debyser, Zeger
    Mortelmans, Luc
    Sijbers, Jan
    Nuyts, Johan
    Baekelandt, Veerle
    Van der Linden, Annemie
    MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2010, 23 (02) : 65 - 75
  • [36] Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease
    Du, Xi-Xun
    Xu, Hua-Min
    Jiang, Hong
    Song, Ning
    Wang, Jun
    Xie, Jun-Xia
    NEUROSCIENCE BULLETIN, 2012, 28 (03) : 253 - 258
  • [37] Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson’s disease discerned with μSPECT and quantitative MRI
    Nadja Van Camp
    Ruth Vreys
    Koen Van Laere
    Erwin Lauwers
    Dirk Beque
    Marleen Verhoye
    Cindy Casteels
    Alfons Verbruggen
    Zeger Debyser
    Luc Mortelmans
    Jan Sijbers
    Johan Nuyts
    Veerle Baekelandt
    Annemie Van der Linden
    Magnetic Resonance Materials in Physics, Biology and Medicine, 2010, 23 : 65 - 75
  • [38] Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson's disease
    Gramage, Esther
    Saiz, Jorge
    Fernandez-Calle, Rosalia
    Martin, Yasmina B.
    Uribarri, Maria
    Ferrer-Alcon, Marcel
    Barbas, Coral
    Herradon, Gonzalo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [39] Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease
    Vercammen, Linda
    Van der Perren, Anke
    Vaudano, Elisabetta
    Gijsbers, Rik
    Debyser, Zeger
    Van den Haute, Chris
    Baekelandt, Veerle
    MOLECULAR THERAPY, 2006, 14 (05) : 716 - 723
  • [40] Hydroxychloroquine attenuated motor impairment and oxidative stress in a rat 6-hydroxydopamine model of Parkinson's disease
    Athari, Seyed Zanyar
    Farajdokht, Fereshteh
    Sadigh-Eteghad, Saeed
    Mohajeri, Daryoush
    Nourazar, Mir Alireza
    Mohaddes, Gisou
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023, 133 (11) : 1252 - 1261